Colin D. Weekes

Harvard University

Full Professor(heuristic)

Pancreatic and Hepatic Oncology Research · Oncology

Compare more Oncology professors.

h-index42
i10-index99
Publications311
Citations15,906

Grants

No NSF/NIH grants on record.

Recent Public Signals

  1. New paper: A phase II study of FOLFIRINOX (FFX) combined with the glycogen synthase kinase-3beta (GSK-3β) inhibitor elraglusib (ELRA) and the transforming growth factor beta (TGFβ) inhibitor losartan (LOS) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC). (Journal of Clinical Oncology)2026-05-27
  2. New preprint: Supplementary Figure S2 from A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors2025-01-06

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-6287-4334

Professor Insights

Career Trajectory